Ledger.Open graph →
SEC Form D · filed May 16, 2019

RELMADA THERAPEUTICS, INC

Offering
$10.0M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sergio Traversa · New York, NYExec · DirectorCharles Casamento · New York, NYDirectorPaul Kelly · New York, NYDirectorMaged Shenouda · New York, NYDirectorOttavio Vitolo · New York, NYExecKevin Mcallister · BALTIMORE, MDDirectorDanny Lin · SAN MATEO, CADirectorCorey B. Mulloy · Seattle, WADirectorHoward Davner · Freehold, NJExec · DirectorRocco Lavista · Freehold, NJExecChristopher Bentley · Spring, TXDirectorMason H. Resch · Chicago, ILDirectorTyler J. Resch · Chicago, ILDirectorJonpaul J. Jonkheer · Chicago, ILExec · DirectorDominic A. Bassani · Old Bethpage, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗